Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer

<div>Gene set enrichment analysis (GSEA) of KRAS in TCGA pancreatic cancer (PC) cohort. (a) Genomic landscape and the mutational signatures of PC in TCGA cohort (FireBrowse platform). (b) Significant enrichment of the metabolic-related phenotype in KRAS WT PC patients compared with KRAS MUT PC patients.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Development of a KRAS-Associated Metabolic Risk Model for Prognostic Prediction in Pancreatic Cancer 